Amyloid-ß-independent regulators of tau pathology in Alzheimer disease.

van der Kant, Rik; Goldstein, Lawrence S B; Ossenkoppele, Rik

van der Kant, Rik; Goldstein, Lawrence S B; Ossenkoppele, Rik.

Affiliation

van der Kant R; Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands. r.h.n.vander.kant@vu.nl.
Goldstein LSB; Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands. r.h.n.vander.kant@vu.nl.
Ossenkoppele R; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.

Nat Rev Neurosci ; 21(1): 21-35, 2020 01.

Article in En | MEDLINE | ID: mdl-31780819

Subject(s)

Alzheimer Disease/metabolism; Alzheimer Disease/pathology; Amyloid beta-Peptides/metabolism; tau Proteins/metabolism; Alzheimer Disease/therapy; Animals; Apolipoproteins E/metabolism; Cholesterol/metabolism; Endocytosis; Humans; Microglia/metabolism; Plaque, Amyloid/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyloid beta-Peptides / Tau Proteins / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Nat Rev Neurosci Journal subject: NEUROLOGIA Year: 2020 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google